There are clinically different types of eosinophilic pneumonia (EP) but no study to date has compared pulmonary inflammatory cells between different types of EP, such as acute eosinophilic pneumonia (AEP), chronic eosinophilic pneumonia (CEP) and drug-induced eosinophilic pneumonia (drug-EP). The present study compared bronchoalveolar lavage fluid (BALF) cell findings to elucidate whether the profiles of the pulmonary inflammatory cells were different among the three types of EP.
Introduction
Eosinophilic pneumonia (EP) has been defined as pulmonary infiltration of eosinophils independently of peripheral blood eosinophilia. This pulmonary disorder includes clinically different types of EP and different causes (l-6) . Both acute eosinophilic pneumonia (AEP) (7) and chronic eosinophilic pneumonia (CEP) (8) have been described as idiopathic EP (5). There are some reports concerning the comparison of clinical features between AEP and CEP (9,lO). However, the differences in the profiles of pulmonary inflammatory cells between the two diseases remains unknown. Analysis of bronchoalveolar lavage fluid (BALF) cells is fundamentally important in diagnosis of EP. As it is considered that the findings of BALF cells reflect the inflammatory processes of the lungs, it is suggested that the different types of EP may have distinctive profiles of BALF cells. Drug-induced EP (drug-EP), which has a specific aetiology, is common. The authors considered that it is important to compare idiopathic EP with aetiologyproven EP. The present study was conducted to elucidate the differences of BALF cell findings among AEP, CEP and drug-EP.
Subjects
and Methods
SUBJECTS
Twenty-eight patients with EP, consisting of eight patients with AEP (seven men and one woman, mean age 24.9 + 9.8 years, all smokers), 10 patients with CEP (seven men and three women, mean age 58. 6 & 19.6 years, five smokers and five non-smokers) and 10 patients with drug-EP (five men and five women, mean age 42.3 I-t 19.9 years, four smokers and six non-smokers), were included in this study. Each patient was diagnosed and treated at Kanazawa University Hospital or its related hospitals between 1989 and 1995.
Five of the patients with AEP (1 l), and three of the patients with drug-EP (12,13) were included in the authors' previous reports. Each patient with AEP met the following diagnostic criteria: acute febrile illness of less than 7 days duration; hypoxaemia; diffuse pulmonary infiltrates on chest X-ray films; increased percentage of eosinophils in BALF; absence of possible causes; and either spontaneous improvement or prompt response to corticosteroid therapy with no relapse. Five patients were treated with corticosteroids.
None of them had a history of bronchial asthma. The diagnosis of CEP was made based on the following diagnostic criteria: typical clinical features consistent with CEP (5) As control, the BALF obtained from 10 normal subjects (nine men and one woman, mean age 50.5 & 17.9 years, seven smokers and three non-smokers) was used.
BRONCHOALVEOLAR LAVAGE DIFFERENTIAL CELL COUNTS IN BALF
After part of the BALF was diluted with an equal volume of Turk solution, cells were counted in a Btirker chamber. After the remaining BALF was passed through a double layer of Dacron net, cells were pelleted at 1500 rpm for 10 min and resuspended in 10 ml of RPMI-1640 (Grand Island Biological C., Grand Island, NY, U.S.A.). The fluid was resuspended to a concentration of 2 x lo5 cells ml ~ I. Smears for differential counts were prepared by cytocentrifugation (Cytopin 2, Shadon Southern Instruments, Sewickleyo, U.S.A.) at 800 rpm for 10 min. After staining with May-Grtinwald-Giemsa, differential cell count was done in 300 cells.
LYMPHOCYTE SUBSETS
Each cell suspension was adjusted to a concentration of 2 x lo7 cells ml ~ i. For assay, 10 ul of the monoclonal antibody was added at the proper dilution to 100 ul of the cell suspension. Cells were incubated at 4°C for 30 min, washed twice in phosphate-buffered saline, and then resuspended in 0.3 ml of RPMI-1640. 
Results

DIFFERENTIAL CELL COUNTS IN BALF
The absolute numbers of BALF cells are shown in Fig. 1 . The number of total cells in patients with AEP, CEP and drug-EP were significantly increased compared with that in normal subjects. The number of lymphocytes in patients with AEP and CEP were significantly increased compared with that in normal subjects. The number of neutrophils in patients with AEP was significantly increased compared with that in normal subjects. The numbers of total cells, lymphyocytes, neutrophils and eosinophils in patients with AEP were significantly higher than those in patients with CEP or drug-EP, respectively.
CD4+/CDS+ RATIOS OF LYMPHOCYTES IN BALF
The CD4+lCD8+ ratios of lymphocytes in BALF and peripheral blood (PB) are shown in Fig. 2 . The CD4+/ CD8+ ratio in the BALF from patients with AEP (2.3 + 0.8) was significantly higher than that from normal subjects (1.4 f 0.7). The CD4+/CD8+ ratio in patients with CEP or drug-EP did not differ from that in normal subjects. The CD4+/CD8+ ratio in BALF from patients with AEP was significantly higher than that from patients with drug-EP.
The CD4+/CD89+ ratio of lymphocytes in PB was not different among patients with AEP, CEP and drug-EP and normal subjects.
PERCENTAGE OF HLA-DR+IN CD4+ AND CDs+ LYMPHOCYTES IN BALF
Percentages of HLA-DR+ in CD4+ and CD8+ lymphocytes in BALF and PB are shown in Fig. 3 . Both the percentages of HLA-DR+ in CD4+ and CD8+ cells in BALF from patients with CEP were significantly increased compared with those from normal subjects. The percentage of HLA-DR+ in CD8+ cells in BALF from patients with CEP was significantly higher than that from patient with AEP and drug-EP.
The percentage of HLA-DR+ in CD4+ or CD8+ lymphocytes in PB did not differ among patients with AEP, CEP and drug-EP and normal subjects.
NUCLEAR SEGMENTATION OF EOSINOPHILS IN BALF
Mean numbers of nuclear segmentations in eosinophils in BALF from patients with AEP, CEP and drug-EP are shown in Fig. 4 . There were no significant differences in the number of nuclear segmentations among the three patient groups.
Discussion
The present study compared the profiles of pulmonary inflammatory cells among AEP, CEP and drug-EP. In the results, the numbers of total cells, eosinophils and lymphocytes in BALF from patients with AEP, CEP and drug-EP were increased compared with those from normal subjects. The authors consider that the increases of severe illness. Indeed, in this study, the illness was most eosinophils and lymphocytes in the lungs are fundamental severe in the patients with AEP. It is suggested that the common profiles in all three types of EP. However, the degree of inflammatory cell infiltration, especially neunumber of neutrophils in BALF from patients with AEP trophils, in the lungs is linked to the clinical condition in the was increased significantly compared with those from patients with EP. There is no report showing the increase of normal subjects and patients with CEP and drug-EP. In eosinophils and neutrophils in BALF from AEP compared addition, the numbers of eosinophils and lymphocytes were with those from CEP. In the four patients with AEP also increased significantly in patients with AEP compared reported by Allen et al. (7) the percentage of neutrophils in with CEP and drug-EP. Therefore, the inflammatory cell BALF on admission was increased in three patients, and profile in the lungs of patients with AEP may be characterthe neutrophil percentage was decreased during the recovized by the intensive infiltration, especially the increase of ery phase in the three patients. So, the present authors neutrophils. Clinically, most of the patients with AEP have suspect that the discrepancy of BAL neutrophilia in AEP may be due to the difference of the disease phase (acute VS. recovery) when BAL was performed. Otherwise, as all of the patients with AEP were smokers, it may be claimed that smoking affects the BALF cell findings. There was the same tendency when the BALF cell findings in the smoking patients with CEP and drug-EP were compared with those in AEP (data not shown). On the other hand, the authors also suspect that smoking in young-aged men and women may be related to AEP, because most of the patients with AEP studied were young smokers with a little experience of smoking. The patients with AEP described in previous reports are also comparatively young, but there is insufficient information concerning their smoking state. Future studies to clarify the association between smoking and AEP are needed.
The CD4+/CDS+ ratio of lymphocytes in the BALF from patients with AEP was increased compared with those from normal subjects and patients with CEP and drug-EP. In addition, although there was no certain tendency in the CD4 +/CD8 + ratio in the patients with CEP or drug-EP, the ratio exceeded 1.0 in all patients with AEP. It is suspected that a variety of drugs and/or different types of allergic reactions may be responsible for the indefinite CD4+/CD8+ ratio of BALF lymphocytes in drug-EP. On the other hand, AEP and CEP are idiopathic or aetiology unknown.
It is characteristic of summer-type hypersensitivity pneumonitis that the CD4+/CD8+ ratios of BALF lymphocytes are decreased below 1.0 (14). From these findings, it is suspected that the uniform increase in the CD4 +/CDS + ratios of BALF cells in AEP indicates an antigen and/or allergic reaction as the aetiology.
Next the percentage of HLA-DR+ in CDS + lymphocytes in the BALF from patients with CEP was significantly greater than that from patients with AEP and drug-EP, suggesting that activated lymphocytes, especially activated suppresser T-cells, in BALF from patients with CEP are increased. Although the number of lymphocytes in BALF from patients with CEP was lower than that from patients with AEP, the lymphocytes in BALF from patients with CEP may be characterized by the increased activation of pulmonary suppresser T-cells. In addition, the percentage of HLA-DR+ in CDs+ lymphocytes in the peripheral blood from patients with CEP and drug-EP tended to be increased compared with that in normal subjects and patients with AEP. Causative drugs arrive at the lungs through the venous route in drug-EP, resulting in systemic immunologic reactions such as the increased percentage of HLA-DR + in CD8 + lymphocytes in the peripheral blood. There was no difference in lymphocyte subset in the peripheral blood between the patients with AEP and normal subjects, suggesting that a causative antigen may arrive at the lungs through the respiratory tract but not through the venous route, or allergic reaction may be localized in the lungs in AEP.
Chihara et al. (15) showed hypodensity and nuclear hypersegmentation of pulmonary eosinophils in EP. In addition, they reported that some chemo-attractants and cytokines could induce nuclear hypersegmentation of eosinophils (16). Previously, the present authors have observed that the changes in mean number of nuclear segmentations of eosinophils in BALF were closely linked with the disease activity of EP (unpubl. data). It is speculated that this phenomenon may be associated with the increase of some mediators and/or cytokines which activate eosinophils in the lungs. The present study showed that there were no significant differences in the mean number of nuclear segmentations in eosinophils in BALF among AEP, CEP and drug-EP. Therefore, it is thought that the nuclear hypersegmentation of eosinophils in BALF, one of the indicators for activated eosinophils, is observed commonly regardless of different types of EP. It is suspected that there may be no difference in participating mediators and/or cytokines activating eosinophils in the lungs among the three types of EP.
In conclusion, the BALF cell findings in patients with EP showed some distinctive characteristics in accordance with the type of EP. It is suggested that neutrophils and lymphocytes rather than eosinophils in the lungs may be related to the pathogensis of each type of EP. Consequently, it is recommended that the function of BALF cells should be analysed in accordance with each type of EP in future studies.
